Business Editors
MORRISTOWN, N.J.--(BUSINESS WIRE)--Nov. 28, 2000
Spring, O'Brien & Co. Inc., a New York-based integrated marketing firm, today announced that its Morristown, NJ, office has officially launched its Life Sciences division with the addition of Alfacell Corporation, a leader in the development of ribonucleouses for therapeutic applications.
As public relations counsel, Spring, O'Brien will execute a full communications program for Alfacell and its flagship product, ONCONASE(R), a revolutionary cancer-fighting drug currently in Phase III clinical trials in patients with malignant mesothelioma.
"Home to numerous cutting-edge biotech and pharmaceutical companies, New Jersey has long been billed as the `nation's medicine cabinet,'" said Marc Weinstein, managing partner, Spring, O'Brien New Jersey. "With the addition of Alfacell, we have successfully taken the first step in building our life sciences division and open the door to new opportunities in this sector."
Alfacell is located in Bloomfield, NJ, and can be found on the World Wide Web at http://www.alfacell.com.
Founded in 1982, Spring, O'Brien is a full-service integrated marketing firm specializing in business-to-business and travel and lifestyle. It offers a wide variety of services including public relations, advertising, design and Website development. Spring, O'Brien has affiliate offices across the United States, in major European countries, in Latin America and in the Middle and Far East.
COPYRIGHT 2000 Business Wire
COPYRIGHT 2000 Gale Group
